Global Enasidenib Drugs Market Growth 2024-2031

Report ID: 1358887 | Published Date: Jan 2025 | No. of Page: 70 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Enasidenib Drugs Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Enasidenib Drugs by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Enasidenib Drugs by Country/Region, 2017, 2022 & 2028
    2.2 Enasidenib Drugs Segment by Type
        2.2.1 50mg
        2.2.2 100mg
    2.3 Enasidenib Drugs Sales by Type
        2.3.1 Global Enasidenib Drugs Sales Market Share by Type (2017-2022)
        2.3.2 Global Enasidenib Drugs Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Enasidenib Drugs Sale Price by Type (2017-2022)
    2.4 Enasidenib Drugs Segment by Application
        2.4.1 Hospital
        2.4.2 Pharmacy
    2.5 Enasidenib Drugs Sales by Application
        2.5.1 Global Enasidenib Drugs Sale Market Share by Application (2017-2022)
        2.5.2 Global Enasidenib Drugs Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Enasidenib Drugs Sale Price by Application (2017-2022)
3 Global Enasidenib Drugs by Company
    3.1 Global Enasidenib Drugs Breakdown Data by Company
        3.1.1 Global Enasidenib Drugs Annual Sales by Company (2020-2022)
        3.1.2 Global Enasidenib Drugs Sales Market Share by Company (2020-2022)
    3.2 Global Enasidenib Drugs Annual Revenue by Company (2020-2022)
        3.2.1 Global Enasidenib Drugs Revenue by Company (2020-2022)
        3.2.2 Global Enasidenib Drugs Revenue Market Share by Company (2020-2022)
    3.3 Global Enasidenib Drugs Sale Price by Company
    3.4 Key Manufacturers Enasidenib Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Enasidenib Drugs Product Location Distribution
        3.4.2 Players Enasidenib Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Enasidenib Drugs by Geographic Region
    4.1 World Historic Enasidenib Drugs Market Size by Geographic Region (2017-2022)
        4.1.1 Global Enasidenib Drugs Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Enasidenib Drugs Annual Revenue by Geographic Region
    4.2 World Historic Enasidenib Drugs Market Size by Country/Region (2017-2022)
        4.2.1 Global Enasidenib Drugs Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Enasidenib Drugs Annual Revenue by Country/Region
    4.3 Americas Enasidenib Drugs Sales Growth
    4.4 APAC Enasidenib Drugs Sales Growth
    4.5 Europe Enasidenib Drugs Sales Growth
    4.6 Middle East & Africa Enasidenib Drugs Sales Growth
5 Americas
    5.1 Americas Enasidenib Drugs Sales by Country
        5.1.1 Americas Enasidenib Drugs Sales by Country (2017-2022)
        5.1.2 Americas Enasidenib Drugs Revenue by Country (2017-2022)
    5.2 Americas Enasidenib Drugs Sales by Type
    5.3 Americas Enasidenib Drugs Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Enasidenib Drugs Sales by Region
        6.1.1 APAC Enasidenib Drugs Sales by Region (2017-2022)
        6.1.2 APAC Enasidenib Drugs Revenue by Region (2017-2022)
    6.2 APAC Enasidenib Drugs Sales by Type
    6.3 APAC Enasidenib Drugs Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Enasidenib Drugs by Country
        7.1.1 Europe Enasidenib Drugs Sales by Country (2017-2022)
        7.1.2 Europe Enasidenib Drugs Revenue by Country (2017-2022)
    7.2 Europe Enasidenib Drugs Sales by Type
    7.3 Europe Enasidenib Drugs Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Enasidenib Drugs by Country
        8.1.1 Middle East & Africa Enasidenib Drugs Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Enasidenib Drugs Revenue by Country (2017-2022)
    8.2 Middle East & Africa Enasidenib Drugs Sales by Type
    8.3 Middle East & Africa Enasidenib Drugs Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Enasidenib Drugs
    10.3 Manufacturing Process Analysis of Enasidenib Drugs
    10.4 Industry Chain Structure of Enasidenib Drugs
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Enasidenib Drugs Distributors
    11.3 Enasidenib Drugs Customer
12 World Forecast Review for Enasidenib Drugs by Geographic Region
    12.1 Global Enasidenib Drugs Market Size Forecast by Region
        12.1.1 Global Enasidenib Drugs Forecast by Region (2023-2028)
        12.1.2 Global Enasidenib Drugs Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Enasidenib Drugs Forecast by Type
    12.7 Global Enasidenib Drugs Forecast by Application
13 Key Players Analysis
    13.1 Celgene Corporation
        13.1.1 Celgene Corporation Company Information
        13.1.2 Celgene Corporation Enasidenib Drugs Product Offered
        13.1.3 Celgene Corporation Enasidenib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Celgene Corporation Main Business Overview
        13.1.5 Celgene Corporation Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Enasidenib Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Enasidenib Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of 50mg
    Table 4. Major Players of 100mg
    Table 5. Global Enasidenib Drugs Sales by Type (2017-2022) & (K Units)
    Table 6. Global Enasidenib Drugs Sales Market Share by Type (2017-2022)
    Table 7. Global Enasidenib Drugs Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Enasidenib Drugs Revenue Market Share by Type (2017-2022)
    Table 9. Global Enasidenib Drugs Sale Price by Type (2017-2022) & (USD/Unit)
    Table 10. Global Enasidenib Drugs Sales by Application (2017-2022) & (K Units)
    Table 11. Global Enasidenib Drugs Sales Market Share by Application (2017-2022)
    Table 12. Global Enasidenib Drugs Revenue by Application (2017-2022)
    Table 13. Global Enasidenib Drugs Revenue Market Share by Application (2017-2022)
    Table 14. Global Enasidenib Drugs Sale Price by Application (2017-2022) & (USD/Unit)
    Table 15. Global Enasidenib Drugs Sales by Company (2020-2022) & (K Units)
    Table 16. Global Enasidenib Drugs Sales Market Share by Company (2020-2022)
    Table 17. Global Enasidenib Drugs Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Enasidenib Drugs Revenue Market Share by Company (2020-2022)
    Table 19. Global Enasidenib Drugs Sale Price by Company (2020-2022) & (USD/Unit)
    Table 20. Key Manufacturers Enasidenib Drugs Producing Area Distribution and Sales Area
    Table 21. Players Enasidenib Drugs Products Offered
    Table 22. Enasidenib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Enasidenib Drugs Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Enasidenib Drugs Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Enasidenib Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Enasidenib Drugs Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Enasidenib Drugs Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Enasidenib Drugs Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Enasidenib Drugs Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Enasidenib Drugs Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Enasidenib Drugs Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Enasidenib Drugs Sales Market Share by Country (2017-2022)
    Table 35. Americas Enasidenib Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Enasidenib Drugs Revenue Market Share by Country (2017-2022)
    Table 37. Americas Enasidenib Drugs Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Enasidenib Drugs Sales Market Share by Type (2017-2022)
    Table 39. Americas Enasidenib Drugs Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Enasidenib Drugs Sales Market Share by Application (2017-2022)
    Table 41. APAC Enasidenib Drugs Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Enasidenib Drugs Sales Market Share by Region (2017-2022)
    Table 43. APAC Enasidenib Drugs Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Enasidenib Drugs Revenue Market Share by Region (2017-2022)
    Table 45. APAC Enasidenib Drugs Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Enasidenib Drugs Sales Market Share by Type (2017-2022)
    Table 47. APAC Enasidenib Drugs Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Enasidenib Drugs Sales Market Share by Application (2017-2022)
    Table 49. Europe Enasidenib Drugs Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Enasidenib Drugs Sales Market Share by Country (2017-2022)
    Table 51. Europe Enasidenib Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Enasidenib Drugs Revenue Market Share by Country (2017-2022)
    Table 53. Europe Enasidenib Drugs Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Enasidenib Drugs Sales Market Share by Type (2017-2022)
    Table 55. Europe Enasidenib Drugs Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Enasidenib Drugs Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Enasidenib Drugs Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Enasidenib Drugs Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Enasidenib Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Enasidenib Drugs Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Enasidenib Drugs Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Enasidenib Drugs Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Enasidenib Drugs Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Enasidenib Drugs Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Enasidenib Drugs
    Table 66. Key Market Challenges & Risks of Enasidenib Drugs
    Table 67. Key Industry Trends of Enasidenib Drugs
    Table 68. Enasidenib Drugs Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Enasidenib Drugs Distributors List
    Table 71. Enasidenib Drugs Customer List
    Table 72. Global Enasidenib Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Enasidenib Drugs Sales Market Forecast by Region
    Table 74. Global Enasidenib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Enasidenib Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Enasidenib Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Enasidenib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Enasidenib Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Enasidenib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Enasidenib Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Enasidenib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Enasidenib Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Enasidenib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Enasidenib Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Enasidenib Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Enasidenib Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Enasidenib Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Enasidenib Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Enasidenib Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Enasidenib Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Enasidenib Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Celgene Corporation Basic Information, Enasidenib Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 93. Celgene Corporation Enasidenib Drugs Product Offered
    Table 94. Celgene Corporation Enasidenib Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 95. Celgene Corporation Main Business
    Table 96. Celgene Corporation Latest Developments
List of Figures
    Figure 1. Picture of Enasidenib Drugs
    Figure 2. Enasidenib Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Enasidenib Drugs Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Enasidenib Drugs Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Enasidenib Drugs Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of 50mg
    Figure 10. Product Picture of 100mg
    Figure 11. Global Enasidenib Drugs Sales Market Share by Type in 2021
    Figure 12. Global Enasidenib Drugs Revenue Market Share by Type (2017-2022)
    Figure 13. Enasidenib Drugs Consumed in Hospital
    Figure 14. Global Enasidenib Drugs Market: Hospital (2017-2022) & (K Units)
    Figure 15. Enasidenib Drugs Consumed in Pharmacy
    Figure 16. Global Enasidenib Drugs Market: Pharmacy (2017-2022) & (K Units)
    Figure 17. Global Enasidenib Drugs Sales Market Share by Application (2017-2022)
    Figure 18. Global Enasidenib Drugs Revenue Market Share by Application in 2021
    Figure 19. Enasidenib Drugs Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global Enasidenib Drugs Revenue Market Share by Company in 2021
    Figure 21. Global Enasidenib Drugs Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global Enasidenib Drugs Revenue Market Share by Geographic Region in 2021
    Figure 23. Global Enasidenib Drugs Sales Market Share by Region (2017-2022)
    Figure 24. Global Enasidenib Drugs Revenue Market Share by Country/Region in 2021
    Figure 25. Americas Enasidenib Drugs Sales 2017-2022 (K Units)
    Figure 26. Americas Enasidenib Drugs Revenue 2017-2022 ($ Millions)
    Figure 27. APAC Enasidenib Drugs Sales 2017-2022 (K Units)
    Figure 28. APAC Enasidenib Drugs Revenue 2017-2022 ($ Millions)
    Figure 29. Europe Enasidenib Drugs Sales 2017-2022 (K Units)
    Figure 30. Europe Enasidenib Drugs Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa Enasidenib Drugs Sales 2017-2022 (K Units)
    Figure 32. Middle East & Africa Enasidenib Drugs Revenue 2017-2022 ($ Millions)
    Figure 33. Americas Enasidenib Drugs Sales Market Share by Country in 2021
    Figure 34. Americas Enasidenib Drugs Revenue Market Share by Country in 2021
    Figure 35. United States Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC Enasidenib Drugs Sales Market Share by Region in 2021
    Figure 40. APAC Enasidenib Drugs Revenue Market Share by Regions in 2021
    Figure 41. China Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe Enasidenib Drugs Sales Market Share by Country in 2021
    Figure 48. Europe Enasidenib Drugs Revenue Market Share by Country in 2021
    Figure 49. Germany Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa Enasidenib Drugs Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa Enasidenib Drugs Revenue Market Share by Country in 2021
    Figure 56. Egypt Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country Enasidenib Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of Enasidenib Drugs in 2021
    Figure 62. Manufacturing Process Analysis of Enasidenib Drugs
    Figure 63. Industry Chain Structure of Enasidenib Drugs
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Enasidenib Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Enasidenib Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Enasidenib Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Global Idhifa Market

As the global economy mends, the 2021 growth of Idhifa will have significant change from previous ... Read More